Search
for
Sort by
Research 421–450 of 1000+
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Association of Suicidality and Depression With 5α-Reductase Inhibitors
- Targeting Wnt/β-Catenin Pathway for Developing Therapies for Hair Loss
- Alopecia Areata Update
- Clinical and biological impact of the exposome on the skin
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Regeneration of skin appendages and nerves: current status and further challenges
- Insulin Resistance and Skin Diseases
- Physiology of the Hypothalamic Pituitary Gonadal Axis in the Male
- Plant cell culture as emerging technology for production of active cosmetic ingredients
- Stress-related skin disorders
- Alopecia areata: An update
- Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
- Neuronal plasticity of the “brain–skin connection”: stress-triggered up-regulation of neuropeptides in dorsal root ganglia and skin via nerve growth factor-dependent pathways
- Mechanism of Sleep Disturbance in Children with Atopic Dermatitis and the Role of the Circadian Rhythm and Melatonin
- Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study
- Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Botulinum Toxin Off-Label Use in Dermatology: A Review
- TOXIC EPIDERMAL NECROLYSIS
- Premature graying of hair
- Endocrine-skin interactions
- Primary cicatricial alopecia: Recent advances in understanding and management
- Female type of adult acne: Physiological and psychological considerations and management
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- Adrenal Disorders and the Paediatric Brain: Pathophysiological Considerations and Clinical Implications